{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T21:04:47Z","timestamp":1771707887354,"version":"3.50.1"},"reference-count":17,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"OBJECTIVE<\/jats:title>Convection-enhanced delivery (CED) has been explored as a therapeutic strategy for diffuse intrinsic pontine glioma (DIPG). Variables that may affect tolerance include infusate volume, infusion rate, catheter trajectory, and target position. Supratentorial approaches for catheter placement and infusate distribution patterns may conflict with corticospinal tracts (CSTs). The clinical relevance of these anatomical constraints has not been described. The authors report their experience using CED in the brainstem as it relates to anatomical CST conflict and association with clinical tolerance.<\/jats:p><\/jats:sec>METHODS<\/jats:title>In a phase I clinical trial of CED for DIPG (clinical trial registration no. NCT01502917, clinicaltrials.gov), a flexible infusion catheter was placed with MRI guidance for infusion of 124<\/jats:sup>I-8H9, a radioimmunotherapeutic agent. Intra- and postprocedural MR images were analyzed to identify catheter trajectories and changes in T2-weighted signal intensity to approximate volume of distribution (Vd). Intersection of CST by the catheter and overlap between Vd and CST were recorded and their correlation with motor deficits was evaluated.<\/jats:p><\/jats:sec>RESULTS<\/jats:title>Thirty-one patients with a mean age of 7.6 years (range 3.2\u201318 years) underwent 39 catheter insertions for CED between 2012 and 2017. Thirty catheter insertions had tractography data available for analysis. The mean trajectory length was 105.5 mm (range 92.7\u2013121.6 mm). The mean number of intersections of CST by catheter was 2.2 (range 0\u20133) and the mean intersecting length was 18.9 mm (range 0\u201344.2 mm). The first 9 infusions in the highest dose level (range 3.84\u20134.54 ml infusate) were analyzed for Vd overlap with CST. In this group, the mean age was 7.6 years (range 5.8\u201310.3 years), the mean trajectory length was 109.5 mm (range 102.6\u2013122.3 mm), and the mean overlap between Vd and CST was 5.5 cm3<\/jats:sup>. For catheter placement\u2013related adverse events, 1 patient (3%) had worsening of a contralateral facial nerve palsy following the procedure with two CST intersections, an intersecting distance of 31.7 mm, and an overlap between Vd and CST of 3.64 cm3<\/jats:sup>. For infusion-related adverse events, transient postinfusion deficits were noted in 3 patients in the highest dose level, with a mean number of 2 intersections of CST by catheter, mean intersecting length of 12.9 mm, and mean overlap between Vd and CST of 6.3 cm3<\/jats:sup>.<\/jats:p><\/jats:sec>CONCLUSIONS<\/jats:title>A supratentorial approach to the brainstem crossing the CST resulted in one worsened neurological deficit. There does not appear to be a significant risk requiring avoidance of dominant motor fiber tracts with catheter trajectory planning. There was no correlation between Vd\u2013CST overlap and neurological adverse events in this cohort.<\/jats:p>Clinical trial registration no.: NCT01502917 (clinicaltrials.gov)<\/jats:p><\/jats:sec>","DOI":"10.3171\/2018.6.jns18854","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:14:41Z","timestamp":1551226481000},"page":"1812-1818","source":"Crossref","is-referenced-by-count":8,"title":["Clinical tolerance of corticospinal tracts in convection-enhanced delivery to the brainstem"],"prefix":"10.3171","volume":"131","author":[{"given":"Peter F.","family":"Morgenstern","sequence":"first","affiliation":[{"name":"Departments of Neurological Surgery and"},{"name":"Departments of Neurosurgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Wembacher-Schr\u00f6der","sequence":"additional","affiliation":[{"name":"BrainLAB, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Cina","sequence":"additional","affiliation":[{"name":"BrainLAB, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos John","family":"Tsiouris","sequence":"additional","affiliation":[{"name":"Radiology, NewYork-Presbyterian Hospital, Weill Cornell Medicine, New York;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark M.","family":"Souweidane","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"},{"name":"Departments of Neurosurgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"J Neurosurg Pediatr","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3171\/2012.10.PEDS12142","article-title":"Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children","volume":"11","author":"Anderson RC","year":"2013","unstructured":"Anderson RC, Kennedy B, Yanes CL, Garvin J, Needle M, Canoll P, : Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children. J Neurosurg Pediatr 11:289\u2013295, 201310.3171\/2012.10.PEDS1214223240851"},{"key":"b2","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00701-013-1700-6","article-title":"Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma","volume":"155","author":"Barua NU","year":"2013","unstructured":"Barua NU, Lowis SP, Woolley M, O\u2019Sullivan S, Harrison R, Gill SS: Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma. Acta Neurochir (Wien) 155:1459\u20131465, 201310.1007\/s00701-013-1700-6"},{"key":"b3","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3171\/2014.11.JNS131888","article-title":"Accuracy of direct magnetic resonance imaging-guided placement of drug infusion cannulae","volume":"122","author":"Chittiboina P","year":"2015","unstructured":"Chittiboina P, Heiss JD, Lonser RR: Accuracy of direct magnetic resonance imaging-guided placement of drug infusion cannulae. J Neurosurg 122:1173\u20131179, 201510.3171\/2014.11.JNS13188825594325"},{"key":"b4","series-title":"Stereotact Funct Neurosurg","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000335502","article-title":"Stereotactic biopsy for brainstem tumors: comparison of transcerebellar with transfrontal approach","volume":"90","author":"Dellaretti M","year":"2012","unstructured":"Dellaretti M, Reyns N, Touzet G, Dubois F, Gusm\u00e3o S, Pereira JL, : Stereotactic biopsy for brainstem tumors: comparison of transcerebellar with transfrontal approach. Stereotact Funct Neurosurg 90:79\u201383, 201210.1159\/00033550222286495"},{"key":"b5","series-title":"J Neurosurg Pediatr","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3171\/2017.2.PEDS1665","article-title":"Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases","volume":"20","author":"Hamisch C","year":"2017","unstructured":"Hamisch C, Kickingereder P, Fischer M, Simon T, Ruge MI: Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. J Neurosurg Pediatr 20:261\u2013268, 201710.3171\/2017.2.PEDS166528621573"},{"key":"b6","series-title":"J Neurosurg Pediatr","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3171\/PED\/2008\/1\/4\/270","article-title":"Diffusion tensor imaging of brainstem tumors: axonal degeneration of motor and sensory tracts","volume":"1","author":"Helton KJ","year":"2008","unstructured":"Helton KJ, Weeks JK, Phillips NS, Zou P, Kun LE, Khan RB, : Diffusion tensor imaging of brainstem tumors: axonal degeneration of motor and sensory tracts. J Neurosurg Pediatr 1:270\u2013276, 200810.3171\/PED\/2008\/1\/4\/27018377301"},{"key":"b7","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/neuonc\/nop054","article-title":"Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma","volume":"12","author":"Kunwar S","year":"2010","unstructured":"Kunwar S, Chang S, Westphal M, Vogelbaum M, Sampson J, Barnett G, : Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol 12:871\u2013881, 201010.1093\/neuonc\/nop05420511192"},{"key":"b8","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/JCO.2006.08.1117","article-title":"Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group","volume":"25","author":"Kunwar S","year":"2007","unstructured":"Kunwar S, Prados MD, Chang SM, Berger MS, Lang FF, Piepmeier JM, : Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 25:837\u2013844, 200710.1200\/JCO.2006.08.1117"},{"key":"b9","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/JNS-07\/07\/0190","article-title":"Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note","volume":"107","author":"Lonser RR","year":"2007","unstructured":"Lonser RR, Warren KE, Butman JA, Quezado Z, Robison RA, Walbridge S, : Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg 107:190\u2013197, 20071763989410.3171\/JNS-07\/07\/0190"},{"issue":"2 Suppl","key":"b10","series-title":"J Neurosurg","first-page":"108","article-title":"Brainstem stereotactic biopsy sampling in children","volume":"104","author":"Pincus DW","year":"2006","unstructured":"Pincus DW, Richter EO, Yachnis AT, Bennett J, Bhatti MT, Smith A: Brainstem stereotactic biopsy sampling in children. J Neurosurg 104 (2 Suppl):108\u2013114, 200616506498"},{"key":"b11","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11060-016-2166-1","article-title":"Stereotactic biopsy of brainstem lesions: 21 years experiences of a single center","volume":"129","author":"Quick-Weller J","year":"2016","unstructured":"Quick-Weller J, Lescher S, Bruder M, Dinc N, Behmanesh B, Seifert V, : Stereotactic biopsy of brainstem lesions: 21 years experiences of a single center. J Neurooncol 129:243\u2013250, 201610.1007\/s11060-016-2166-127291894"},{"issue":"1 Suppl","key":"b12","series-title":"J Neurosurg","first-page":"1","article-title":"Stereotactic biopsy of diffuse pontine lesions in children","volume":"107","author":"Roujeau T","year":"2007","unstructured":"Roujeau T, Machado G, Garnett MR, Miquel C, Puget S, Geoerger B, : Stereotactic biopsy of diffuse pontine lesions in children. J Neurosurg 107 (1 Suppl):1\u20134, 200717647306"},{"key":"b13","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1215\/15228517-2008-012","article-title":"Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors","volume":"10","author":"Sampson JH","year":"2008","unstructured":"Sampson JH, Akabani G, Archer GE, Berger MS, Coleman RE, Friedman AH, : Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors. Neuro Oncol 10:320\u2013329, 200810.1215\/15228517-2008-01218403491"},{"key":"b14","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3171\/2009.11.JNS091052","article-title":"Poor drug distribution as a possible explanation for the results of the PRECISE trial","volume":"113","author":"Sampson JH","year":"2010","unstructured":"Sampson JH, Archer G, Pedain C, Wembacher-Schr\u00f6der E, Westphal M, Kunwar S, : Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg 113:301\u2013309, 20102002084110.3171\/2009.11.JNS091052"},{"key":"b15","series-title":"Oncol Lett","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3892\/ol.2014.2680","article-title":"Role of high-field intraoperative magnetic resonance imaging on a multi-image fusion-guided stereotactic biopsy of the basal ganglia: a case report","volume":"9","author":"Sun X","year":"2015","unstructured":"Sun X, Chen Z, Yang S, Zhang J, Yue S, Wang Z, : Role of high-field intraoperative magnetic resonance imaging on a multi-image fusion-guided stereotactic biopsy of the basal ganglia: a case report. Oncol Lett 9:223\u2013226, 201510.3892\/ol.2014.268025435963"},{"key":"b16","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1227\/01.NEU.0000350229.77462.2F","article-title":"Anatomic compression caused by high-volume convection-enhanced delivery to the brain","volume":"65","author":"Valles F","year":"2009","unstructured":"Valles F, Fiandaca MS, Bringas J, Dickinson P, LeCouteur R, Higgins R, : Anatomic compression caused by high-volume convection-enhanced delivery to the brain. Neurosurgery 65:579\u2013586, 200910.1227\/01.NEU.0000350229.77462.2F"},{"key":"b17","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1227\/01.neu.0000303199.77370.9e","article-title":"Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results","volume":"61","author":"Vogelbaum MA","year":"2007","unstructured":"Vogelbaum MA, Sampson JH, Kunwar S, Chang SM, Shaffrey M, Asher AL, : Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. Neurosurgery 61:1031\u20131038, 20071809127910.1227\/01.neu.0000303199.77370.9e"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/131\/6\/article-p1812.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/131\/6\/article-p1812.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/131\/6\/article-p1812.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T04:30:38Z","timestamp":1742704238000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/131\/6\/article-p1812.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":17,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2018.6.jns18854","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}